Formulation and Drug Delivery

Pharmapack Report Points to Inhaled Pulmonary and Intranasal Drug Delivery as Areas to Watch

January 26, 2024

The annual industry report of the Pharmapack Europe event suggests there will be significant innovation in inhaled pulmonary and intranasal drug delivery in 2024.

Winners of the 2024 Pharmapack Europe Awards are Announced

January 25, 2024

The 2024 Pharmapack Europe Award winners include companies involved in ground-breaking innovations in novel drug delivery solutions, reusable connected devices, and recyclable packaging.

Takeda’s Subcutaneous Immunoglobulin Receives FDA Approval for Maintenance Therapy of Rare Neuromuscular Disorder

January 24, 2024

Takeda has received FDA approval for HYQVIA, a subcutaneous immunoglobulin for the maintenance treatment of chronic inflammatory demyelinating polyneuropathy.

A Platform for mRNA Platforms

January 11, 2024

Regulators from around the world will gather to help shape the mRNA and RNA therapeutics landscape at an exceptional April 2024 Washington, D.C. convocation.

Relative Bioavailability Trial of Nanotechnology-Enhanced Enzalutamide is Underway

January 10, 2024

Nanoform has completed the First Subject First Visit in a trial evaluating the relative bioavailability of its nanotechnology-enhanced enzalutamide.

DoD Grants Additional Funds to MediWound for Advancement of Non-Surgical Treatment for Field Care Burns

January 05, 2024

MediWound has been granted an additional $6.7 million by the DoD to advance NexoBrid as a non-surgical field care solution for the US military.

Bristol Myers Squibb and SystImmune Enter Global ADC Collaboration Worth Potentially up to $8.4 Billion

December 19, 2023

Bristol Myers Squibb and SystImmune plan to co-develop and co-commercialize lead ADC candidate for cancer treatment in US.

Compounding Overview: Primary Considerations in the Workplace

December 18, 2023

Technical, regulatory, and personnel considerations characterize pharmaceutical compounding.

Selecting Excipients for Enhancing Solubility of Hot-Melt Extrusion Formulations

December 03, 2023

Matching excipients to API properties is essential.

Risks and Rewards of Investing in RNA-based Genetic Medicine Manufacturing

December 03, 2023

Collaboration is a key component to achieving long-term success with genetic medicines.